Ensysce Biosciences Inc expected to post a loss of $2.73 a share - Earnings Preview

Ensysce Biosciences

08/08/2023 03:05

* Ensysce Biosciences Inc  ENSC.OQ   ENSC.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 9
(estimated). 
    * The La Jolla California-based  company is expected to
report  a
298.5% increase in revenue to $826.67 thousand from $207.47
thousand a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Ensysce Biosciences
Inc
is for a loss of $2.73 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts had risen by
about 53.4%
in the last three months. ​
    * Wall Street's median 12-month price target for Ensysce
Biosciences Inc is $16.33​, above​ its last closing price
of $1.88. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -5.44       -5.08      -2.08     Beat    59
 Dec. 31 2023  -30.85      -28.88     -18.24    Beat    36.8
 Sep. 30 2022  -38.40      -38.40     -8.88     Beat    76.9​
 Jun. 30 2022  -31.20      -40.80     -57.60    Missed  -41.2
 ​​Mar.        -38.40      -38.40     -14.40    Beat    62.5
 31 2022                                                
 Dec. 31 2021  21.60       -4.80      -1.08     Missed  -2,150
                                      hundred           ​
 This summary was machine generated August 8 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated